{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:33:19Z","timestamp":1769149999826,"version":"3.49.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103021","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T22:12:09Z","timestamp":1406153529000},"page":"e103021","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["PIK3CA Gene Mutations and Overexpression: Implications for Prognostic Biomarker and Therapeutic Target in Chinese Esophageal Squamous Cell Carcinoma"],"prefix":"10.1371","volume":"9","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaokai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"PC Enzinger","year":"2003","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Prabhu A, Obi KO, Rubenstein JH (2014) The Synergistic Effects of Alcohol and Tobacco Consumption on the Risk of Esophageal Squamous Cell Carcinoma: A Meta-Analysis. Am J Gastroenterol.","DOI":"10.1038\/ajg.2014.71"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bpg.2007.10.001","article-title":"The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer","volume":"21","author":"R Lambert","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref4","first-page":"541","article-title":"[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer]","volume":"31","author":"HL Zhang","year":"2009","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1304227110","article-title":"Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma","volume":"110","author":"JJ Gartner","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Song Y, Li L, Ou Y, Gao Z, Li E, <etal>et al<\/etal>.. (2014) Identification of genomic alterations in oesophageal squamous cell cancer. Nature advance online publication.","DOI":"10.1038\/nature13176"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e41655","DOI":"10.1371\/journal.pone.0041655","article-title":"High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations","volume":"7","author":"CH Maeng","year":"2012","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2013.09.011","article-title":"Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma","volume":"45","author":"J Hou","year":"2014","journal-title":"Hum Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/aps.2013.163","article-title":"PIK3CA hypomethylation plays a key role in activation of the PI3K\/AKT pathway in esophageal cancer in Chinese patients","volume":"34","author":"WF Wang","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1158\/1078-0432.CCR-12-3559","article-title":"PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma","volume":"19","author":"H Shigaki","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3892\/ijo_00000202","article-title":"Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma","volume":"34","author":"I Akagi","year":"2009","journal-title":"Int J Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jss.2007.03.044","article-title":"PIK3CA mutation status in Japanese esophageal squamous cell carcinoma","volume":"145","author":"R Mori","year":"2008","journal-title":"J Surg Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"TL Yuan","year":"2008","journal-title":"Oncogene"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nrc1753","article-title":"Oncogenic PI3K deregulates transcription and translation","volume":"5","author":"AG Bader","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.cco.0000198021.99347.b9","article-title":"Oncogenic PI3K and its role in cancer","volume":"18","author":"Y Samuels","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Y Samuels","year":"2004","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.0510857103","article-title":"Cancer-specific mutations in PIK3CA are oncogenic in vivo","volume":"103","author":"AG Bader","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0701005104","article-title":"Rare cancer-specific mutations in PIK3CA show gain of function","volume":"104","author":"M Gymnopoulos","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1158\/0008-5472.CAN-09-3752","article-title":"Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo","volume":"70","author":"H Zhang","year":"2010","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1158\/1078-0432.CCR-10-2882","article-title":"The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations","volume":"17","author":"H Tanaka","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref21","first-page":"503","article-title":"The novel dual PI3K\/mTOR inhibitor GDC-0941 synergizes with the MEK inhibitor U0126 in non-small cell lung cancer cells","volume":"5","author":"ZQ Zou","year":"2012","journal-title":"Mol Med Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00280-012-1869-z","article-title":"Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines","volume":"69","author":"A Mueller","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.celrep.2013.12.035","article-title":"Assessing PIK3CA and PTEN in early-phase trials with PI3K\/AKT\/mTOR inhibitors","volume":"6","author":"F Janku","year":"2014","journal-title":"Cell Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.18632\/oncotarget.716","article-title":"PIK3CA mutations in advanced cancers: characteristics and outcomes","volume":"3","author":"F Janku","year":"2012","journal-title":"Oncotarget"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1158\/1535-7163.MCT-10-0994","article-title":"PIK3CA mutations in patients with advanced cancers treated with PI3K\/AKT\/mTOR axis inhibitors","volume":"10","author":"F Janku","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2310\/JIM.0b013e318276de92","article-title":"A retrospective evaluation of radiotherapy for the treatment of local esophageal squamous cell carcinoma recurrence after initial complete surgical resection","volume":"61","author":"YL Zhu","year":"2013","journal-title":"J Investig Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canlet.2013.04.005","article-title":"Genetic deregulation of the PIK3CA oncogene in oral cancer","volume":"338","author":"AK Murugan","year":"2013","journal-title":"Cancer Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FOXO transcription factors at the interface between longevity and tumor suppression","volume":"24","author":"EL Greer","year":"2005","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.humpath.2004.12.009","article-title":"Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features","volume":"36","author":"T Odajima","year":"2005","journal-title":"Hum Pathol"},{"key":"ref30","volume":"7","unstructured":"Maeng CH, Lee J, van Hummelen P, Park SH, Palescandolo E, <etal>et al<\/etal>.. (2012) High-Throughput Genotyping in Metastatic Esophageal Squamous Cell Carcinoma Identifies Phosphoinositide-3-Kinase and BRAF Mutations. Plos One <volume>7<\/volume>.."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1158\/1078-0432.CCR-12-3559","article-title":"PIK3CA Mutation Is Associated with a Favorable Prognosis among Patients with Curatively Resected Esophageal Squamous Cell Carcinoma","volume":"19","author":"H Shigaki","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/ijc.21706","article-title":"Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett&apos;s esophagus","volume":"118","author":"WA Phillips","year":"2006","journal-title":"Int J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/sj.onc.1209311","article-title":"Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients","volume":"25","author":"Y Tanaka","year":"2006","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1078-0432.CCR-05-2173","article-title":"PIK3CA mutations in head and neck squamous cell carcinoma","volume":"12","author":"W Qiu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","article-title":"Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic","volume":"102","author":"S Kang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"N Chalhoub","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/annonc\/mdt280","article-title":"Family history of cancer and the risk of cancer: a network of case-control studies","volume":"24","author":"F Turati","year":"2013","journal-title":"Ann Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.25532","article-title":"Does family history of cancer modify the effects of lifestyle risk factors on esophageal cancer? A population-based case-control study in China","volume":"128","author":"M Wu","year":"2011","journal-title":"Int J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3748\/wjg.v18.i28.3745","article-title":"PI3K expression and PIK3CA mutations are related to colorectal cancer metastases","volume":"18","author":"YF Zhu","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-009-0508-9","article-title":"PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis","volume":"122","author":"MA Aleskandarany","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humpath.2012.05.005","article-title":"PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma","volume":"44","author":"A Abe","year":"2013","journal-title":"Hum Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3748\/wjg.v16.i39.4986","article-title":"Up-regulation of PIK3CA promotes metastasis in gastric carcinoma","volume":"16","author":"JF Liu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref43","first-page":"589","article-title":"AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells","volume":"61","author":"S Tanno","year":"2001","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.bjc.6604782","article-title":"Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells","volume":"99","author":"J Kikuchi","year":"2008","journal-title":"Br J Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/bcr2594","article-title":"Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer","volume":"12","author":"CJ Creighton","year":"2010","journal-title":"Breast Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/carcin\/bgr303","article-title":"PI3K\/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer","volume":"33","author":"M Riggio","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1158\/1078-0432.CCR-07-1046","article-title":"Down-regulation of phosphatidylinositol 3\u2032-kinase\/AKT\/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer","volume":"14","author":"D Generali","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1074\/jbc.M010840200","article-title":"Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance","volume":"276","author":"RA Campbell","year":"2001","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T03:42:03Z","timestamp":1565667723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103021"}},"subtitle":[],"editor":[{"given":"Hiromu","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103021","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]}}}